They’re often diagnosed at later stages with tumors with more aggressive features.
—
Angus Chen,
STAT,
29 Oct. 2026
Researchers are studying the cancer-killing drug trastuzumab rezetecan for those with ERBB2-low metastatic breast cancer, whose tumors have low levels of HER2, a protein that can help cancer cells grow.
Now researchers are investigating whether certain cancers, such as breast cancer, could be added to that list.
—
Lori Youmshajekian,
Scientific American,
8 June 2026
Over time, follow-on R&D added over 40 indications across numerous cancers — including early-stage applications that allow treatment to begin before cancer worsens.
Examples are automatically compiled from online sources to
show current usage.Read More
Opinions expressed in the examples do not represent those of Merriam-Webster or its editors.
Send us feedback.